Renalytix Plc (RNLXY)
OTCMKTS · Delayed Price · Currency is USD
0.2200
-0.0200 (-8.33%)
Sep 17, 2025, 1:40 PM EDT
Renalytix Market Cap
Renalytix has a market cap or net worth of $33.03 million as of September 17, 2025. Its market cap has increased by 44.20% in one year.
Market Cap
33.03M
Enterprise Value
31.48M
Revenue
2.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.22
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 84.47M to 33.03M, a decrease of -60.90%. That is a compound annual growth rate of -12.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 35.03M | -21.41% |
| Dec 31, 2024 | 44.57M | 125.93% |
| Dec 29, 2023 | 19.73M | -69.84% |
| Dec 30, 2022 | 65.42M | -89.22% |
| Dec 31, 2021 | 607.05M | 26.62% |
| Dec 31, 2020 | 479.42M | 67.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 792.01M |
| Elite Pharmaceuticals | 718.26M |
| Glass House Brands | 567.62M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |